| 13th National Haemostasis Update (NHU 2024) September 6, 2024 (Friday) |
|||||
| (The timings mentioned are as per the Indian Standard Time – IST) | |||||
| 07:30 – 08:50 | Registration | ||||
| Hall A | |||||
| 08:50 – 09:00 | Welcome Note | ||||
| Time (IST) | Topic | Speaker/Chair | |||
| 09:00 – 09:40 | Plenary 1 | Co-Chairs: Chandrakala S, King Edward Memorial Hospital, Mumbai |
|||
| 09:00 – 09:30 | Redefining Goals of Haemophilia Therapy in the Era of Non-Factor Replacement |
Guy Young, Children’s Hospital, Los Angeles (Virtual) |
|||
| 09:30 – 09:40 | Discussion | ||||
| Hall A | Hall B | ||||
| Time (IST) | Topic | Speaker/Chair | Topic | Speaker/Chair | |
| 09:45 – 11:00 | Scientific Session 1A Theme: Von Willebrand Disease |
Co-Chairs: Shyh-Shin Chiou, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung. Naresh Gupta, Maulana Azad Medical College, New Delhi |
Scientific Session 1B Theme: MSK |
Chair: Nittu Panjikaran, Amrita Institute of Medical Science, Kochi. |
|
| 09:45 – 10:10 | Challenges in von Willebrand Disease Diagnosis in Low- and Middle-Income Countries: The Way Forward | Jasmina Ahluwalia, PGIMER Chandigarh, Chandigarh. |
Radioactive Synovectomy | Naveen Cherian Thomas, Christian Medical College, Vellore. |
|
| 10:10 – 10:35 | Shifting Paradigms: Genomic Diagnosis as an Effective Substitute For Functional Testing in Von Willebrand Disease for Low Middle Income Countries | Michelle Lavin, National Coagulation Centre, St. James’s Hospital, Dublin. |
Panel Discussion – Ankle Treatment Options |
Moderator: Naveen Cherian Thomas, Christian Medical College, Vellore. Panelist: a) Rohini Dange, Sahyadri Hospital, Pune. b) Shigy Francis, Lisie Hospital, Ernakulum. c) Mohd. Helmi Bin Hashim, Hospital Sultanah Bahiyah, Alor Setar. |
|
| 10:35 – 11:00 | Improving von Willebrand Disease Outcomes in Low- and Middle-Income Countries | Jameela Sathar, Hospital Ampang, Ampang. |
Osteoporosis in PwH | Kumiko Ono, The University of Tokyo, Tokyo (Virtual) |
|
| 11:00 – 11:30 | Tea Break with Poster Viewing | ||||
| 11:35 – 12:35 | Symposium I: Novo Nordisk (Room 1) One Factor Many Possibilities |
Symposium II: Takeda (Room 2) Revisiting Management of Patients with CHAWI – From Expert Opinion to Clinical Decision Mode of Conducting the Activity: F2F |
|||
| 11:35 – 11:40 | Welcome and Introduction | Dr. Naresh Gupta | 1:35 – 11:37 | Welcome Note | Takeda Medical Affairs Team |
| The Multiple Indications of Extended Half Life Factors | 11:37 – 11:40 | Context setting and Introduction to speaker | Alok Srivastava, Christian Medical College Vellore |
||
| 11:40 – 11:55 | Use in Prophylaxis | TBD | 11:40 – 12:00 | Co-treatment of BPA with non-factor therapy in CHAWI patients | Guy Young, Children’s Hospital Los Angeles |
| 11:55 – 12:10 | Use in Surgery | TBD | 12:00 – 12:10 | Q & A | Moderator: Alok Srivastava, Christian Medical College Vellore Panelist: Guy young, Children’s Hospital Los Angeles Tulika Seth, AIIMS, New Delhi Chandrakala S, King Edward Memorial Hospital, Mumbai Neeraj Sidharthan, AIMS, Cochin |
| The Horizon of rFVIIa | 12:10 – 12:20 | Role of APCC in CHAWI patients undergoing surgery | Chandrakala S, King Edward Memorial Hospital, Mumbai |
||
| 12:10 – 12:25 | Managing breakthrough bleeds in inhibitor patients | TBD | 12:20 – 12:32 | Q & A | Moderator: Chandrakala S Panelist: Alok Srivastava, Guy young, Tulika Seth, Neeraj Sidharthan |
| 12:25 – 12:35 | Panel Discussion & Q/A | All | 12:32 – 12:35 | Concluding Remarks | Alok Srivastava |
| 12:35 – 13:30 | Lunch | ||||
| 13:35 – 14:30 | Scientific Session 2A Theme: Bridging Trends in Haemophilia |
Co-Chairs: Jiaan Der Wang, Taichung Veterans General Hospital, Taichung Neeraj Sidharthan, Amrita Institute of Medical Sciences, Kochi |
13:35 – 14:30 | Scientific Session 2B (Nursing) |
Chair: Divya Varghese, St John’s Medical College Hospital, Bengaluru |
| Time (IST) | Topic | Speaker/Chair | Time (IST) | Topic | Speaker/Chair |
| 13:35 – 14:00 | Emerging Trends in The Management Acquired Haemophilia A | Nguyen Thi Mai, National Institute of Hematology and Blood Transfusion, Hanoi |
13:35 – 13:40 | Introduction | |
| 14:00 – 14:30 | Panel Discussion – Newly Diagnosed Haemophilia: Insights from Different Countries |
Moderator: Rattapan Lamool, Pramongkut Hospital, Bangkok. Panelists: |
13:40 – 13:55 | Haemophilia Nurse in Asia-Pacific: The insider Stories |
Lim Chiew Ying, KK Women’s and Children’s Hospital, Singapore |
| 13:55 – 14:10 | Professional Framework for Becoming a Specialist Haemophilia Nurse | Alex Klever, Royal Brisbane and Women’s Hospital, Queensland |
|||
| 14:10 – 14:25 | Snapshots of 3 Haemophilia Treatment Centres in Asia Pacific |
a) Radhika Basi, Civil Service Hospital, Kathmandu b) Dita Rizkiya Yusnita, Dr Cipto Mangunkusumo Hospital, Jakarta c) Aoi Nakazawa, Ogikubo Hospital, Tokyo (Virtual) |
|||
| 14:25 – 14:30 | Discussion | ||||
| Hall A | |||||
| 14:35 – 15:15 | Plenary 2 | Co-Chairs: Jameela Sathar, Hospital Ampang, Ampang Meera V, Bangalore Medical College and Research Institute, Bangalore |
|||
| 14:35 – 15:05 | Health Economic and Haemophilia Care: Value, Innovation, and Access. | Louis Garrison, University of Washington, Washington (Virtual) |
|||
| 15:05 – 15:15 | Discussion | ||||
| 15:20 – 16:20 | Sponsored Symposium III: Roche Room 1 Chairperson: Dr Naresh Gupta |
Sponsored Symposium IV: Octa Pharma Room 2 |
|||
| Time (IST) | Topic | Speaker | Time (IST) | Topic | Speaker/Chair |
| 15:20 – 15:30 | Single centre Experience of Emicizumab | Vaishali Joshi, GMC, Goa | 15:20 – 15:27 | Welcome and Introduction | Craig Kessler, US |
| 15:30 – 15:40 | Surgical experience with Emicizumab | Cecil Ross, St. Johns, Banglore | 15:27 – 15:42 | The Enduring Relevance of FVIII in Haemophilia A Management | Anthony Chan, Canada |
| 15:40 – 15:50 | Single centre Experience of Emicizumab: Adult patients | Bilal Ahmed Sheikh, SMHS, Srinagar | 15:42 – 15:57 | Making Informed Treatment Decisions for Prophylaxis in Haemophilia A | Craig Kessler, US |
| 15:50 – 16:20 | Optimal care in Hemophilia: Role of Emicizumab | Moderator: Anupam Dutta, AMCH, Guwahati Panelists: Rahul R, NHM, Kerala Vishnu Sharma, SMS, Jaipur Sunita Aggarwal, LNJP, Delhi S P Verma, KGMU, Lucknow Usha Rani, Niloufer Varun Kaul, GGMCH, Faridkot Tulika Seth, AIIMS, New Delhi |
15:57 – 16:02 | Navigating the Unique Challenges in VWD | Predrag Miljic, Serbia |
| 16:02 – 16:20 | Q&A | All Faculty | |||
| 16:20 – 16:50 | Tea Break with Poster Viewing | ||||
| Hall A | Hall B | ||||
| Time (IST) | Topic | Speaker/Chair | Topic | Speaker/Chair | |
| 16:55 – 18:10 | Scientific Session 3A Theme: Difficult Bleeds in Haemophilia Care: Challenges and Solutions |
Co-Chairs: Chean Sophal, National Pediatric Hospital, Phnom Penh Soniya Nityanand, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow |
Scientific Session 3B Theme: Advances in Diagnosing Bleeding Disorders |
Co-Chairs: Tien Sim Leng, Singapore General Hospital, Singapore Renu Saxena, Medanta, Gurgaon |
|
| 16:55 – 17:20 | Recurrent Pseudotumours in Haemophilia: Evidence Based management | Tulika Seth, All India Institute of Medical Sciences, New Delhi. |
The Institutional Approach for Diagnosis and Management of Children with Bleeding of Unknown Cause | Nongnuch Sirachainan, Ramathibodi Hospital, Bangkok. |
|
| 17:20 – 17:45 | Optimal Treatment Strategies in Prevention of Intracranial Bleeding in Haemophilia Patients | Meera B Chitlur, Children’s Hospital of Michigan, Detroit. |
Haemostasis Lab in the Era of NFCs. | Bert Verbruggen, Radboud University Nijmegen Medical Centre, The Netherlands. |
|
| 17:45 – 18:10 | Managing Major Bleeds in Inhibitor-Positive Haemophilia: Challenges and Innovations | Darintr Sosothikul, Chulalongkorn University, Bangkok. |
How to Make Diagnosis of Bleeding Disorders Accessible and Cost Effective? | Nitty S Mathews, Christian Medical College, Vellore |
|
| 19:30 onwards | Dinner with Invited Guests | ||||
